Yin Lu Selected Research

5- (3- hydroxypropyl)- 7- methoxy- 2- (3'- methoxy- 4'- hydroxyphenyl)- 3- benzo(b)furancarbaldehyde

2/2010

[Advances in studies on antitumor activities of compounds in Salvia miltiorrhiza].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yin Lu Research Topics

Disease

60	Neoplasms (Cancer) 06/2022 - 08/2009
22	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2009
18	Inflammation (Inflammations) 10/2022 - 01/2012
15	Fibrosis (Cirrhosis) 09/2021 - 02/2012
13	Melanoma (Melanoma, Malignant) 06/2022 - 08/2009
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
9	Carcinogenesis 01/2021 - 07/2014
9	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015 - 02/2012
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2012
7	Body Weight (Weight, Body) 01/2020 - 08/2009
6	Carcinoma (Carcinomatosis) 01/2021 - 02/2012
4	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2014
4	Hypoxia (Hypoxemia) 01/2022 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2017
4	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2015
3	Infections 01/2021 - 01/2019
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 01/2020
3	Skin Neoplasms (Skin Cancer) 07/2020 - 07/2015
3	Leukemia 01/2019 - 02/2012
3	Pathologic Processes 02/2017 - 03/2012
3	Hyperlipidemias (Hyperlipidemia) 12/2015 - 09/2013
2	Cognitive Dysfunction 10/2022 - 01/2022
2	Nasopharyngeal Carcinoma 01/2022 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 04/2020
2	Multiple Myeloma 11/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 03/2019
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
2	Colitis 01/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2013
2	Obesity 01/2021 - 01/2020
2	Hyperalgesia 11/2020 - 01/2012
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 09/2013

Drug/Important Bio-Agent (IBA)

12	cryptotanshinoneIBA 01/2021 - 02/2010
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2010
9	CytokinesIBA 01/2022 - 01/2014
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021 - 08/2009
7	Messenger RNA (mRNA)IBA 01/2021 - 02/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
6	EnzymesIBA 01/2020 - 02/2012
6	xanthatinIBA 12/2017 - 03/2012
6	CurcuminIBA 11/2015 - 06/2012
6	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2015 - 02/2012
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021 - 08/2010
4	CateninsIBA 06/2022 - 07/2013
4	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2017
4	tanshinoneIBA 01/2022 - 02/2010
4	LipidsIBA 09/2021 - 08/2015
4	anthraceneIBA 07/2020 - 07/2014
4	Acetates (Acetic Acid Esters)FDA Link 07/2020 - 07/2014
4	CarcinogensIBA 01/2020 - 07/2014
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 09/2014
4	IntegrinsIBA 12/2015 - 01/2012
4	tetramethylpyrazineIBA 12/2015 - 08/2009
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2022 - 01/2021
3	salvianolic acid BIBA 01/2022 - 02/2010
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2013
3	NAD (NADH)IBA 11/2020 - 01/2020
3	Therapeutic UsesIBA 01/2020 - 11/2012
3	paeonolIBA 01/2020 - 07/2013
3	Pyruvate KinaseIBA 10/2019 - 01/2014
3	AntioxidantsIBA 01/2018 - 07/2014
3	diallyl trisulfideIBA 01/2018 - 05/2014
3	TOR Serine-Threonine KinasesIBA 01/2017 - 08/2010
3	GlycosaminoglycansIBA 12/2015 - 01/2013
3	LigandsIBA 12/2015 - 01/2013
3	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 01/2013
3	Thymidine Monophosphate (TMP)IBA 04/2015 - 02/2013
3	3,4-dihydroxyphenyllactic acidIBA 09/2014 - 09/2010
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2014 - 03/2012
2	Caspase 1 (ICE Protease)IBA 10/2022 - 01/2022
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022 - 01/2022
2	Melanins (Melanin)IBA 06/2022 - 04/2011
2	Glycogen Synthase (Synthase I)IBA 06/2022 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	toripalimabIBA 01/2022 - 01/2021
2	Estrogen ReceptorsIBA 01/2021 - 01/2012
2	PhytochemicalsIBA 01/2021 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017
2	Menthol FDA Link 01/2021 - 08/2015
2	Caspase 3 (Caspase-3)IBA 11/2020 - 10/2020
2	daphnetinIBA 04/2020 - 07/2019
2	Hemostatics (Antihemorrhagics)IBA 01/2020 - 08/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2019
2	Tight Junction ProteinsIBA 01/2020 - 01/2012
2	LycopeneIBA 01/2020 - 07/2014
2	Ion Channels (Ion Channel)IBA 11/2019 - 01/2019
2	elemeneIBA 10/2019 - 04/2011
2	beta-elemeneIBA 10/2019 - 04/2011
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2017
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 08/2015
2	Cantharidin (Cantharides)IBA 01/2019 - 08/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 06/2010
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2015
5	Immunotherapy 01/2022 - 03/2019
5	Chemoprevention 07/2020 - 09/2011
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 09/2013
3	Acupuncture Therapy 12/2012 - 02/2012